Chris H Takimoto
CIK 1743780 · CHIEF MEDICAL OFFICER · last filed 2026-01-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
31
Lifetime Open-Market Net
-$9.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ALXO | Director | — | $1.58 | — | $0 | 2 | 2026-01-21 |
| IGM Biosciences, Inc. (IGMS) Delisted | CHIEF MEDICAL OFFICER | 154,331 | $1.27 | $196.0K | -$277.4K | 17 | 2024-09-17 |
| Forty Seven, Inc. (FTSV) Delisted | Chief Medical Officer | 0 | — | — | -$8.90M | 12 | 2020-04-07 |
Recent Filings · Page 4 of 4
31 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-01-08 | Forty Seven, Inc. (FTSV) Delisted | Mixed | — | -$108.2K | EDGAR |
Showing 31–31 of 31
Prev
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.